Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$509M |
| 2 |
Mastercard
MA
|
+$404M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$401M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$302M |
| 5 |
Intuit
INTU
|
+$277M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arthur J. Gallagher & Co
AJG
|
+$416M |
| 2 |
Coca-Cola
KO
|
+$394M |
| 3 |
Starbucks
SBUX
|
+$374M |
| 4 |
Salesforce
CRM
|
+$351M |
| 5 |
PNC Financial Services
PNC
|
+$268M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.34% |
| 2 | Financials | 9.88% |
| 3 | Consumer Discretionary | 8.94% |
| 4 | Industrials | 7.09% |
| 5 | Healthcare | 6.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VRNA
1026
PUT
DELISTED
Verona Pharma
VRNA
| $7.94M | 0.01% |
+125,000
| New | +$7.48M |
|
1027
CALL
Ionis Pharmaceuticals
IONS
$10.5B
| $7.84M | 0.01% |
+260,000
| New | +$8.51M |
|
1028
Unilever
UL
$140B
| $7.83M | 0.01% |
116,929
+98,653
| +540% | +$6.36M |
|
|
AZEK
1029
CALL
DELISTED
The AZEK Co
AZEK
| $7.82M | 0.01% |
+160,000
| New | +$7.58M |
|
1030
CALL
Howard Hughes
HHH
$3.94B
| $7.81M | 0.01% |
+105,400
| New | +$7.96M |
|
1031
Warner Bros
WBD
$72.2B
| $7.79M | 0.01% |
726,457
-1,354,621
| -65% | -$14.2M |
|
1032
Marvell Technology
MRVL
$217B
| $7.79M | 0.01% |
126,523
-722,863
| -85% | -$70.1M |
|
1033
Perella Weinberg Partners
PWP
$1.23B
| $7.78M | 0.01% |
423,068
+223,345
| +112% | +$5.07M |
|
1034
Cameco
CCJ
$46.8B
| $7.78M | 0.01% |
188,909
-889,461
| -82% | -$41.9M |
|
|
LGF.B
1035
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $7.74M | 0.01% |
976,886
-29,084
| -3% | -$233K |
|
1036
Ameren
AEE
$29.8B
| $7.72M | 0.01% |
+76,902
| New | +$7.4M |
|
1037
The RealReal
REAL
$1.34B
| $7.72M | 0.01% |
1,431,922
+1,407,833
| +5,844% | +$10.7M |
|
1038
Myriad Genetics
MYGN
$298M
| $7.65M | 0.01% |
862,787
+779,405
| +935% | +$9.36M |
|
1039
CALL
Freeport-McMoran
FCX
$113B
| $7.65M | 0.01% |
202,100
+69,600
| +53% | +$2.66M |
|
1040
PUT
Super Micro Computer
SMCI
$24.5B
| $7.63M | 0.01% |
222,800
+116,800
| +110% | +$4.43M |
|
|
CTRA
1041
DELISTED
Coterra Energy
CTRA
| $7.61M | 0.01% |
263,164
+187,929
| +250% | +$5.24M |
|
1042
FTAI Infrastructure
FIP
$444M
| $7.6M | 0.01% |
1,678,723
-403,165
| -19% | -$2.52M |
|
1043
Lockheed Martin
LMT
$131B
| $7.6M | 0.01% |
17,004
-31,902
| -65% | -$14.7M |
|
|
TGI
1044
DELISTED
Triumph Group
TGI
| $7.59M | 0.01% |
+299,546
| New | +$6.93M |
|
1045
PUT
Avis
CAR
$5.12B
| $7.59M | 0.01% |
+100,000
| New | +$8.04M |
|
1046
Kinsale Capital Group
KNSL
$8.9B
| $7.58M | 0.01% |
+15,572
| New | +$6.99M |
|
1047
Hamilton Insurance Group
HG
$3.45B
| $7.58M | 0.01% |
365,432
+211,696
| +138% | +$4.13M |
|
1048
ADMA Biologics
ADMA
$2.15B
| $7.57M | 0.01% |
+381,707
| New | +$6.6M |
|
|
VRE
1049
DELISTED
Veris Residential
VRE
| $7.57M | 0.01% |
447,394
-38,582
| -8% | -$623K |
|
1050
Clarivate
CLVT
$1.3B
| $7.56M | 0.01% |
+1,922,579
| New | +$9.11M |
|
Similar funds
Dmitry Balyasny's Q1 2025 Portfolio in Review
As of Q1 2025, Dmitry Balyasny held 3,423 positions worth $60.5B, down 9.9% from $67.1B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Dmitry Balyasny withdrew a net $4.05B in Q1 2025, closing 697 positions and reducing 920 holdings. Its most notable exit was Starbucks, an estimated $374M position sold in full.
By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 10% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Dmitry Balyasny opened a new position in AutoZone worth $255M.
- Dmitry Balyasny's largest Q1 2025 buy was AutoZone: 66,934 shares worth $255M.
- Dmitry Balyasny added most to iShares Core S&P 500 ETF in Q1 2025, an estimated $509M increase.
- Dmitry Balyasny's biggest Q1 2025 reduction was Arthur J. Gallagher & Co, cutting an estimated $416M.
- Dmitry Balyasny fully exited Starbucks in Q1 2025, selling an estimated $374M.
- Dmitry Balyasny's ten largest holdings make up 13% of its $60.5B portfolio in Q1 2025.
- Dmitry Balyasny opened 759 new positions and closed 697 in Q1 2025.
- Dmitry Balyasny's portfolio value fell 9.9% quarter-over-quarter to $60.5B.
Based on Balyasny Asset Management's 13F filing for Q1 2025, filed 15 May 2025.